⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28747840 | 0.97 | — | — | |
| SCHEMBL27503919 | 0.97 | — | — | |
| SCHEMBL5385190 | 0.78 | — | — | |
| SCHEMBL17333587 | 0.78 | — | — | |
| SCHEMBL3740860 | 0.76 | — | — | |
| SCHEMBL363785 | 0.73 | — | — | |
| SCHEMBL10440719 | 0.73 | — | — | |
| SCHEMBL22845128 | 0.72 | — | — | |
| SCHEMBL9741697 | 0.71 | — | — | |
| SCHEMBL9372878 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110090226-A | For the treating cancer in cancer patient and the method for predicting medicine response | 利普拉森制药有限公司 | 2019-08-06 | — | — | CN | claimed |
| CN-110325212-A | The farnesyl transferase inhibitor of method for treating cancer | 库拉肿瘤学公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110090226-A | For the treating cancer in cancer patient and the method for predicting medicine response | 利普拉森制药有限公司 | 2019-08-06 | — | — | CN | disclosed |
| CN-107001603-B | water-soluble polycarbonate for medical applications | 国际商业机器公司 | 2018-12-25 | — | — | CN | disclosed |
| CN-108779111-A | In conjunction with the compound of deoxycytidine kinase | 加利福尼亚大学董事会 | 2018-11-09 | — | — | CN | disclosed |
| CN-108371711-A | Use the method for farnesyl transferase inhibitor treating cancer patient | 库拉肿瘤学公司 | 2018-08-07 | — | — | CN | disclosed |
| CN-107787373-A | Methods of treating cancer patients with farnesyl transferase inhibitors | 库拉肿瘤学公司 | 2018-03-09 | — | — | CN | disclosed |
| CN-105833791-B | Surfactant containing o-nitrobenzyl ester photodegradation group and preparation method thereof | 大连理工大学 | 2017-10-24 | — | — | CN | disclosed |
| US-9760006-B2 | Silicon-containing resist underlayer film forming composition having urea group | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| CN-106170557-A | As the micropopulation compositions of chemotherapy answer logo thing, and microbial modulator (prebiotics, probiotic bacteria or symphysis unit) is for improving the purposes for the treatment of of cancer effect | 古斯达威罗斯研究所 | 2016-11-30 | — | — | CN | disclosed |
| CN-1882609-A | Altering B cell pathology using self-derived antigen binding specific binding cytoreductive agents | FAVRILLE INC (US) | 2006-12-20 | — | — | CN | disclosed |
| CN-1119395-C | Two-stage fraction oil hydrogenating and arene eliminating process | CHINA PETROCHEMICAL CORP (CN) | 2003-08-27 | — | — | CN | disclosed |
| CN-1088405-C | Preparation method of catalyst containing molecular sieve and noble metal | CHINA PETROCHEMICAL CORP (CN) | 2002-07-31 | — | — | CN | disclosed |
| CN-1081223-C | Process for preparing bimetallic catalyst containing pt and pd | CHINA PETROCHEMICAL CORP (CN) | 2002-03-20 | — | — | CN | disclosed |
| CN-1267709-A | Two-stage fraction oil hydrogenating and arene eliminating process | CHINA PETROCHEMICAL CORP (CN) | 2000-09-27 | — | — | CN | disclosed |
| CN-1228357-A | Method for preparing catalyst comprising molecular sieve and noble metal | CHINA PETROCHEMICAL CORP (CN) | 1999-09-15 | — | — | CN | disclosed |
| US-5908919-A | DRUG DELIVERY | TERRAPIN TECHNOLOGIES (US) | 1999-06-01 | — | — | US | disclosed |
| EP-0832101-A2 | URETHANE MEDIATED, GST SPECIFIC MOLECULAR RELEASE SYSTEMS | TERRAPIN TECHNOLOGIES, INC. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040739-A2 | URETHANE MEDIATED, GST SPECIFIC MOLECULAR RELEASE SYSTEMS | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| CN-86103798-A | The preparation method of N-phenyl-4-phenyl-1-piperazine carbonamidine and their purposes as anti-arrhythmic | — | 1987-06-10 | — | — | CN | disclosed |